Selank 10mg Research Peptide

For Research Purposes Only. Not approved for human consumption. For laboratory research use only.

Selank Anxiolytic Research Peptide

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, derived from the endogenous neuropeptide tuftsin (Thr-Lys-Pro-Arg) with additional stabilizing residues (Pro-Gly-Pro). It has been extensively studied in Russian research programs for anxiolytic, nootropic, and immunomodulatory effects. Selank’s mechanism involves interaction with GABAergic, serotonergic, and dopaminergic systems, as well as upregulation of brain-derived neurotrophic factor (BDNF) — making it a multifaceted research tool for neuroscience investigations. Unlike classical benzodiazepines, Selank research suggests anxiolytic effects without sedation or dependence in animal models, generating significant research interest in its mechanism of action.

Research Applications

• Anxiolytic mechanism and GABAergic pathway research
• BDNF upregulation and neuroprotection studies
• Serotonin and dopamine metabolism investigations
• Cognitive function and memory consolidation research
• Immunomodulation and cytokine regulation studies
• Stress response and HPA axis research

Quality Specifications

• Purity: ≥98% (HPLC and mass spectrometry verified)
• Compound: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
• Molecular Weight: 751.9 Da
• Form: Lyophilized powder
• Storage: -20°C, protect from light and moisture
• COA: Batch-specific, third-party ISO-accredited laboratory

Frequently Asked Questions

Q: What is Selank’s primary mechanism in research models?
A: Selank modulates GABAergic transmission, increases BDNF expression, influences serotonin turnover, and regulates cytokine levels including IL-6 and interferon. It is unique in demonstrating anxiolytic properties without the sedation or dependence observed with classical GABA modulators in research models.

Q: How does Selank differ from Semax?
A: Both are Russian-developed synthetic neuropeptides, but they have distinct mechanisms. Selank is primarily studied for anxiolytic and immunomodulatory effects. Semax is primarily studied for neuroprotection, BDNF upregulation, and cognitive enhancement. They are sometimes studied together for complementary effects.

Q: What immunomodulatory effects has Selank shown in research?
A: Research has documented Selank’s ability to regulate IL-6, interferon, and other cytokines. It appears to have bidirectional immunomodulatory effects — enhancing immune response under suppression and reducing it under excessive activation, making it valuable for immune regulation research.

Related Research: Semax Neuroprotective Peptide | NAD+ Cellular Energy | Research Peptide Quality Guide | KPV Tripeptide Research Peptide

For laboratory research use only. Not for human consumption. Not evaluated by the FDA. These statements have not been evaluated by the Food and Drug Administration.